×
AbbVie Revenue 2012-2026 | ABBV
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
AbbVie revenue for the twelve months ending March 31, 2026 was
$62.819B
, a
9.5% increase
year-over-year.
AbbVie annual revenue for 2025 was
$61.16B
, a
8.57% increase
from 2024.
AbbVie annual revenue for 2024 was
$56.334B
, a
3.71% increase
from 2023.
AbbVie annual revenue for 2023 was
$54.318B
, a
6.44% decline
from 2022.
View More
AbbVie Revenue 2012-2026 | ABBV
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
AbbVie annual revenue for 2025 was
$61.16B
, a
8.57% increase
from 2024.
AbbVie annual revenue for 2024 was
$56.334B
, a
3.71% increase
from 2023.
AbbVie annual revenue for 2023 was
$54.318B
, a
6.44% decline
from 2022.
Related Stocks
Company Name
Market
Cap
Eli Lilly (LLY)
$887.6B
Johnson & Johnson (JNJ)
$574.4B
Roche Holding AG (RHHBY)
$318.8B
Merck (MRK)
$299.9B
Novartis AG (NVS)
$294B
Novo Nordisk (NVO)
$167.5B
Pfizer (PFE)
$153.1B
Sanofi (SNY)
$114B
Bayer (BAYRY)
$46.2B
Innoviva (INVA)
$1.8B